HomeClinics HomeAbout ClinicsAll ClinicsHot TopicsAdvancesSpecial OffersCME
Logo
Search for

Volume 38, Issue 2, Pages 373-388 (June 2009)


View previous. 12 of 17 View next.

Thyroid-Associated Orbitopathy: Who and How to Treat

Jane Dickinson, MBChB, FRCP, FRCOphthaCorresponding Author Informationemail address, Petros Perros, MBBS, MD, FRCPb

Thyroid-associated orbitopathy is the most frequent and troublesome nonthyroidal complication of Graves' disease. It is mandatory to determine whether sight-threatening orbitopathy is present, as this requires prompt and aggressive treatment. Therapies for non–sight-threatening disease range from supportive measures only to medical therapies for active eye disease and surgical rehabilitation for burnt-out disease. Intravenous steroids and orbital radiotherapy are the mainstays of medical therapy. Rehabilitative surgery is frequently a staged process that may involve sequentially: orbital decompression, strabismus surgery, and eyelid procedures. Smoking cessation is recommended at all disease stages. Treatment within a multidisciplinary team consisting of both endocrinologists and ophthalmologists may lead to optimal patient outcomes.

a Department of Ophthalmology, Newcastle upon Tyne Hospitals NHS Trust, Queen Victoria Road, Newcastle upon Tyne NE1 4LP UK

b Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Trust, Queen Victoria Road, Newcastle upon Tyne NE1 4LP UK

Corresponding Author InformationCorresponding author. Department of Ophthalmology, Newcastle upon Tyne Hospitals NHS Trust, Queen Victoria Road, Newcastle upon Tyne NE1 4LP UK.

PII: S0889-8529(09)00005-X

doi:10.1016/j.ecl.2009.01.004


View previous. 12 of 17 View next.